Related Experiment Videos

Framework for headache management in pediatric patients with stroke and cerebrovascular lesions: A narrative review

Allison C Hyland1,2,3,4, Samuel J Belfer3,4, Christine K Fox1

  • 1Department of Neurology and Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.

Headache
|August 11, 2026
PubMed

Insights

Managing headaches in pediatric stroke patients requires careful drug selection due to vascular risks. Non-pharmacologic therapies and addressing underlying vascular lesions offer promising, safer options for these complex cases.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Vascular Neurology

Background:

  • Chronic headache is a common complication following ischemic or hemorrhagic stroke in pediatric patients.
  • Pediatric patients with cerebrovascular disorders and headaches present unique treatment challenges due to medication vasoactivity.
  • Standard headache medications may increase cerebrovascular risk in this vulnerable population.

Purpose of the Study:

  • To establish an evidence-based framework for managing headache disorders in pediatric patients with prior stroke or cerebral vascular lesions.
  • To evaluate the safety and efficacy of pharmacologic and non-pharmacologic headache therapies in this population.
  • To provide guidance on drug selection considering vascular pathophysiology and hemodynamic stability.

Main Methods:

  • A comprehensive MEDLINE literature review was conducted, searching for headache medication classes and specific neurovascular conditions.
  • Included studies were published in English or translated, dating from 1990, and encompassed various study types (in vitro/in vivo, reviews, case series/reports).
  • Extracted data were organized by vascular condition, summarizing preventive and acute interventions based on efficacy, safety, and theoretical risk.

Main Results:

  • Vasoconstrictive agents (triptans, ergots) are generally contraindicated due to risks of ischemia or hemorrhage.
  • Anti-hypertensive agents (beta-blockers, CCBs, ARBs) are considered safe and may offer vascular benefits.
  • Non-pharmacologic therapies, anti-seizure medications, antidepressants, and melatonin show favorable risk-benefit profiles, though data are limited. Interventions targeting vascular lesions often improve headaches.

Conclusions:

  • Individualized headache management is crucial for pediatric patients with cerebrovascular disease.
  • Drug selection must account for vascular pathophysiology, hemodynamic stability, and collateral flow.
  • Further prospective, pediatric- and lesion-specific studies are needed to optimize headache therapies.
Abstract

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.